Introduction
Leptospirosis is a zoonotic infection found worldwide but which is mostly endemic to subtropical and tropical areas. The genus Leptospira consists of > 250 serovars which cause a wide spectrum of disease manifestations ranging from a mild febrile illness to severe lifethreatening disease in humans. Diagnostic tests used to make a definitive diagnosis do not provide timely results and may not be available in certain clinical settings. As a result, patients are often treated empirically for undifferentiated febrile syndromes with broad antimicrobial therapy that provide coverage of various local etiologies of fever.
Despite its worldwide distribution, only a small number of randomized, controlled clinical trials looking at treatment have been performed (5, 11, 18, 19, 22, 24) . These studies have been conducted in a limited number of locations, including Barbados, Panama, Philippines, and Thailand, and in only two were the causative Leptospira serovars or serogroups reported. A survival benefit of one agent over another has not been demonstrated in prior studies; however, a reduction of symptoms and leptospiruria has been described. There are multiple in vitro and in vivo (animal) studies showing a wide variety of antimicrobials have potential value in treating this disease (1-3, 6-8, 10, 12-16, 17, 20, 23, 25 ).
We have previously described an in vitro broth microdilution technique that allows reliable, rapid testing of antimicrobial susceptibilities, permitting efficient evaluation of multiple antimicrobials and Leptospira serovars (15) . This method was used successfully to evaluate multiple antibiotics against 26 Leptospira serovars (16). Although most of the strains previously studied by our group were recovered initially from human infections, they were all maintained by subculture as laboratory strains for a great number of years. Recently, we have received clinical human isolates from different leptospirosis endemic areas to assess the activity of
A C C E P T E D
on August 15, 2017 by guest http://aac.asm.org/ Downloaded from various antimicrobial agents. These isolates have been passed in animal models to maintain virulence or have undergone less than 5 subcultures since initial collection. The goals of this study were to evaluate the in vitro activity of various antimicrobial agents against these isolates to determine if there are regional differences in susceptibility patterns and to compare the susceptibility of recent clinical human isolates and animal lethal strain to those previously reported using long-term laboratory maintained strains.
Materials and methods
Leptospira isolates. Thirteen Leptospira isolates representing 3 different species and at least 6 serovars were included in testing. These included 10 human clinical isolates that have undergone less than 5 subcultures since initial collection and 3 isolates that have been maintained in our lethal animal models ( Table 1) Antibiotics. Stock antimicrobial solutions were prepared from reagent-grade powders to produce 1mg/ml solutions using solvents and diluents as suggested in the Clinical and Laboratory Standards Institute document M100-S17 (4) or per the manufacturer suggestions as available. A total of 13 antimicrobials were tested (Table 2) . Ceftriaxone, cefotaxime, doxycycline, penicillin G, and tetracycline were purchased from Sigma-Aldrich (St. Louis, MO). Icterohaemorrhagiae strain used in this study has been assessed for internal validation with MIC parameters previously described in a study validating this MIC technique (15) .
Results
The median MICs of three runs are reported in Table 2 PFGE was performed to compare the leptospiral strains in this collection (Figure 1 ). The three human clinical strains obtained from AFRIMS Thailand could not be matched in the current CDC database for any known leptospiral serovars. These strains, therefore, may be unique serovars not previously described.
Discussion
Patients who present with a febrile illness, especially in the tropics, are often treated empirically with various antimicrobial agents in attempts to cover a broad array of bacterial pathogens in the differential diagnosis in which leptospirosis is included. We have previously shown that a large These findings had not been confirmed using clinical isolates from around the world that have not been serially passed in a laboratory (with the possible loss of virulence). In this study we have shown that numerous antimicrobials from different classes are active against a diverse collection of pathogenic isolates. We have found that regional differences in susceptibility may exist. The tetracycline antibiotics in this study were found to have increased activity against strains passed in animals in comparison to the human clinical isolates. When comparing our previously reported results from similar serovars of laboratory-passed strains to this virulent strain collection, similarities in susceptibility patterns are noted for most antimicrobial agents, with cefepime and the macrolides producing the lowest MICs in both groups (16) . The main differences observed between this study and our past work include the increased activity of ampicillin and penicillin G to these virulent strains compared to the laboratory passed strains.
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The obverse is noted for imipenem/cilastatin, which was less active against the human isolates in the current collection.
Ampicillin, cefepime, and the macrolides had the best in vitro activity with MICs below the limit of detection against all strains in this collection. All antimicrobials had lower MIC 90 s than the traditional antileptospiral drug doxycycline and the closely related drug tetracycline.
The remaining antimicrobial agents had MIC 90 s equal to or less than penicillin G, with cefotaxime having the lowest MIC 90 of the traditional antileptospiral agents.
Given that a serovar-specific diagnosis is not readily available or feasible in most instances, an assortment of serovars from diverse geographical locations including three possible novel serovars from Thailand were chosen to allow for comparison of strains and locations. It is interesting to note that doxycycline and tetracycline had higher MICs among strains obtained Leptospirosis has recently received attention in Egypt as an important etiology of acute febrile illness, especially in those patients who present with acute hepatitis (9, 21) . It is unclear why the MICs for doxycycline and tetracycline are higher in the Egypt isolates, although it has been reported that many patients with acute febrile illness in this region are empirically diagnosed with typhoid and treated with either ampicillin or tetracycline (9) . Thus, one can postulate that this decrease in susceptibility is associated with local drug pressure. This requires further analysis.
Lastly, most of the antimicrobials seemed to be more active against the strains passed in animals compared with the human clinical isolates, producing lower median MICs by two dilutions or more. The reasoning for this phenomenon in these strains is not clear since virulence should be maintained by inoculation into animals; however, virulence is not a direct measure of susceptibility to antimicrobials. In addition, the location of the only animal passed strain that we know of, Nicaragua, is different than the other clinical strains and, thus, there might be further regional antimicrobial resistance pattern differences. This observation is especially evident for the only L. kirschneri in this isolate collection, possibly representing species variation to antimicrobial susceptibility. It does not seem that this species is more susceptible to antimicrobials in general as some laboratory strains of the same species have a more resistant susceptibility profile (16) . The lethal animal strains 11 and 13 had higher penicillin G MICs compared to the other strains.
The main limitation of our study is that it is in vitro data and despite our isolate collection being representative of different geographic locations, it is not all inclusive. Correlation of in vitro susceptibility data to treatment outcomes in humans is lacking, although in vivo animal studies with strain 11 have correlated well with our in vitro testing (7, 12, 13) .
In summary, the thirteen tested virulent Leptospira strains from geographically distinct regions, from both human disease and lethal animal models, are susceptible to a range of antimicrobial agents. Newer and non-traditional antimicrobials show good activity against this strain collection, but our study suggests there may be regional differences as well as differences in strains passed through animals. As such, further analysis of strains from around the world needs to be undertaken and the impact of serial passage on resistance profiles in animals models is needed as this is often the preliminary stages of assessing antimicrobials prior to human trials. 

